Evidence map›Paper›PMID 23601474›Full record

ArticleBMC genetics2013

Genomic deletion of CNGB3 is identical by descent in multiple canine breeds and causes achromatopsia.

Connie Y Yeh, Orly Goldstein, Anna V Kukekova, Debbie Holley, Amy M Knollinger, Heather J Huson, Susan E Pearce-Kelling, Gregory M Acland, András M Komáromy

Open access · diamondAbstract read
In one paragraph

Article in BMC genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Canine and Feline Models of Inherited Retinal Diseases.Cold Spring Harbor perspectives in medicine · 2024
    Review
  3. Article
  4. Achromatopsia: Genetics and Gene Therapy.Molecular diagnosis & therapy · 2022
    Review
  5. International journal of molecular sciences · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  13. Dog models for blinding inherited retinal dystrophies.Human gene therapy. Clinical development · 2015
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Connie Y Yeh
Orly Goldstein
Anna V Kukekova
Debbie Holley
Amy M Knollinger
Heather J Huson
Susan E Pearce-Kelling
Gregory M Acland
András M Komáromy
Cornell University · USMichigan State University · USAgricultural Research Service · USEye Care Associates · USIthaca College · USUrbana University · USWillow Wood (United States) · US

Funding

MODELS OF HEREDITY RETINAL DEGENERATIONR01EY006855 · NEI · UNIVERSITY OF PENNSYLVANIA · PI GUSTAVO David AGUIRRE, William A. Beltran · 1992 to 2026
$20.7M
Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Qi N Cui · 1985 to 2026
$19.5M
Achromatopsia - Disease Mechanisms and Cone-Directed Gene TherapyR01EY019304 · NEI · UNIVERSITY OF PENNSYLVANIA · PI KOMAROMY, ANDRAS · 2009 to 2013
$2.3M
TRAINING IN COMPARITIVE MEDICAL &MOLECULAR GENETICST32RR007063 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI WOLFE, JOHN H · 1996 to 2011
$1.8M
NCRR NIH HHS T32-RR007063NEI NIH HHS P30-EY001583NEI NIH HHS R01-EY006855NEI NIH HHS R01-EY019304
6 · The paper itself

Abstract

backgroundAchromatopsia is an autosomal recessive disease characterized by the loss of cone photoreceptor function that results in day-blindness, total colorblindness, and decreased central visual acuity. The most common causes for the disease are mutations in the CNGB3 gene, coding for the beta subunit of the cyclic nucleotide-gated channels in cones. CNGB3-achromatopsia, or cone degeneration (cd), is also known to occur in two canine breeds, the Alaskan malamute (AM) and the German shorthaired pointer.

resultsHere we report an in-depth characterization of the achromatopsia phenotype in a new canine breed, the miniature Australian shepherd (MAS). Genotyping revealed that the dog was homozygous for a complete genomic deletion of the CNGB3 gene, as has been previously observed in the AM. Identical breakpoints on chromosome 29 were identified in both the affected AM and MAS with a resulting deletion of 404,820 bp. Pooled DNA samples of unrelated purebred Australian shepherd, MAS, Siberian husky, Samoyed and Alaskan sled dogs were screened for the presence of the affected allele; one Siberian husky and three Alaskan sled dogs were identified as carriers. The affected chromosomes from the AM, MAS, and Siberian husky were genotyped for 147 SNPs in a 3.93 Mb interval within the cd locus. An identical shared affected haplotype, 0.5 Mb long, was observed in all three breeds and defined the minimal linkage disequilibrium (LD) across breeds. This supports the idea that the mutated allele was identical by descent (IBD).

conclusionWe report the occurrence of CNGB3-achromatopsia in a new canine breed, the MAS. The CNGB3-deletion allele previously described in the AM was also observed in a homozygous state in the affected MAS, as well as in a heterozygous carrier state in a Siberian husky and Alaskan sled dogs. All affected alleles were shown to be IBD, strongly suggesting an affected founder effect. Since the MAS is not known to be genetically related to the AM, other breeds may potentially carry the same cd-allele and be affected by achromatopsia.

Indexed as

AnimalsBreedingColor Vision DefectsCyclic Nucleotide-Gated Cation ChannelsDNA Mutational AnalysisDog DiseasesDogsFounder EffectGenotypeLinkage DisequilibriumPhenotypeSequence DeletionCyclic Nucleotide-Gated Cation Channels

Identifiers

PMID23601474
PMCPMC3639114
OpenAlexW2044824735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.